25th February 2022 | Pharma Updates

Why are multinational pharmaceutical corporations restructuring their operations in India?

Multinational drugmakers are reorganising their businesses in India, selling brands, eliminating non-core units, or laying off employees, at a time when the local market is taking centre stage in Indian pharma companies’ growth strategies.

Zydus Lifesciences Limited is the new name for Cadila Healthcare.

The Zydus company revealed its new brand identification on Thursday, with Cadila Healthcare Ltd. becoming Zydus Lifesciences Ltd., the firm’s publicly traded entity.

Exports to Russia and Ukraine may be affected, causing concern among pharmaceutical businesses

Executives in the pharmaceutical industry are concerned that sanctions against Russian banks may have an impact on remittances of outstanding trade receivables from that country.

Novavax has started delivering COVID vaccine to European Union countries

Novavax Inc announced that it has begun sending doses of its COVID-19 vaccine to European Union member states, with France, Austria, and Germany likely to get the shots first in the coming days.

A new two-dose vaccine has shown to be 100 % effective against severe Covid.

The booster trial, which included participants who had previously received shots based on mRNA technology or adenovirus viral vectors, indicated it might increase neutralising antibodies by 18 to 30 times, according to the firms.

Drug has been discovered that could help children with a dangerous Covid-19 complication

According to the researchers, multiinflammatory syndrome in children (MISC) develops weeks to months following a moderate or even asymptomatic occurence of Covid-19.

For the first time, Covid vaccination supply exceeds demand for the global programme

The global sharing project COVID-19 vaccinations are having trouble distributing more than 300 million doses, indicating that the challenge with vaccinating the world is now more about supply than demand.

FDA has approved a treatment for a broader range of heart failure patients

Jardiance (empagliflozin) was licenced by the US Food and Drug Administration to lower the risk of cardiovascular death and heart failure hospitalisation in adults.

Impact of the Russia-Ukraine situation on Indian kitchens, the pharmaceutical industry, crude oil prices, and more

The economic impact of the RussiaUkraine crisis on India is projected to be significant. 90 percent of India’s sunflower oil imports come from Russia and Ukraine. Crude oil, pharmaceutical business, and LNG industry are all expected to suffer.

FDA has approved the first condom meant to prevent HIV infection

According to the US Food and Drug Administration, the first condom particularly intended to prevent the spread of HIV and other sexually transmitted infections during anal sex has been approved for sale in the US.